These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12849298)

  • 41. Immunotherapy of autoimmune disease.
    Cooke A; Wraith DC
    Curr Opin Immunol; 1993 Dec; 5(6):925-33. PubMed ID: 8297526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of autoimmune disease by oral tolerance to autoantigens.
    Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal tolerance and the immunotherapy of autoimmune disease: a commentary.
    Wraith DC; Metzler B
    Ther Immunol; 1995 Feb; 2(1):53-8. PubMed ID: 7553071
    [No Abstract]   [Full Text] [Related]  

  • 44. An introduction to biomaterial-based strategies for curbing autoimmunity.
    Lewis JS; Allen RP
    Exp Biol Med (Maywood); 2016 May; 241(10):1107-15. PubMed ID: 27229905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases.
    Xiao BG; Huang YM; Link H
    BioDrugs; 2003; 17(2):103-11. PubMed ID: 12641489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Oral tolerance in the treatment of rheumatoid arthritis and other autoimmune diseases].
    Torigoe DY; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):96-100. PubMed ID: 9435403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccine against autoimmune disease: antigen-specific immunotherapy.
    Anderson RP; Jabri B
    Curr Opin Immunol; 2013 Jun; 25(3):410-7. PubMed ID: 23478068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases.
    Ma S; Liao YC; Jevnikar AM
    Curr Pharm Biotechnol; 2015; 16(11):1002-11. PubMed ID: 26306744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The goals of immunologic intervention in autoimmune disease.
    Talal N
    J Autoimmun; 1989 Jun; 2 Suppl():257-64. PubMed ID: 2673275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.
    Bai XF; Link H
    Clin Exp Allergy; 2000 Dec; 30(12):1688-96. PubMed ID: 11122206
    [No Abstract]   [Full Text] [Related]  

  • 51. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of autoimmunity in human diseases: a critical review of current dogma.
    Benson RA; Brewer JM; Platt AM
    Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current and future immunotherapy targets in autoimmune neurology.
    Hu MY; Stathopoulos P; O'connor KC; Pittock SJ; Nowak RJ
    Handb Clin Neurol; 2016; 133():511-36. PubMed ID: 27112694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New trends in immunosuppression and immunotherapy.
    Jiang S; Lombardi G
    Int Immunopharmacol; 2006 Dec; 6(13-14):1874-8. PubMed ID: 17161339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?
    Dick AD
    Br J Ophthalmol; 1995 Jan; 79(1):81-8. PubMed ID: 7880799
    [No Abstract]   [Full Text] [Related]  

  • 56. Bench to bedside: new approaches to the immunotherapy of uveitic disease.
    Nussenblatt RB
    Int Rev Immunol; 2002; 21(2-3):273-89. PubMed ID: 12424847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current and future therapies for myasthenia gravis.
    Yi Q; Lefvert AK
    Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.
    Smilek DE; Lock CB; McDevitt HO
    Immunol Rev; 1990 Dec; 118():37-71. PubMed ID: 1706681
    [No Abstract]   [Full Text] [Related]  

  • 59. Experimental autoimmune uveoretinitis: a model system for immunointervention: a review.
    Forrester JV; Liversidge J; Dua HS; Dick A; Harper F; McMenamin PG
    Curr Eye Res; 1992; 11 Suppl():33-40. PubMed ID: 1358557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.